Plaintiffs in valsartan-based drug lawsuits filed over possible carcinogenic contamination may have to make room for additional consumers as lawyers push for the inclusion of two other blood pressure medications, losartan and irbesartan. Batches of the drugs, in addition to valsartan, have been found to be tainted with NDMA, or nitrosodimethylamine. NDMA is a known human carcinogen and has been linked to the development of certain ...
NDMA Contamination Found in Additional Blood Pressure and Diabetes Medications
Posted January 10, 2020 in Drug and Medical Device Lawsuits | Product News and Recalls